Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies
Autore:
Engelfriet, CP; Reesink, HW; Mannucci, PM; Gringeri, A; Ingerslev, J; Brettler, DB; Mauser-Bunschoten, EP; Negrier, C; Berntorp, E; Smith, OP; Shapiro, AD;
Indirizzi:
Serv Sanquin, Cent Lab Blood Transfus, NL-1066 CX Amsterdam, Netherlands Serv Sanquin Amsterdam Netherlands NL-1066 CX CX Amsterdam, Netherlands Blood Bank N Holland Sanquin, NL-1066 CX Amsterdam, Netherlands Blood BankN Holland Sanquin Amsterdam Netherlands NL-1066 CX etherlands Univ Milan, I-20122 Milan, Italy Univ Milan Milan Italy I-20122Univ Milan, I-20122 Milan, Italy IRCCS Maggiore Hosp, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, I-20122 Milan, Italy IRCCS Maggiore Hosp Milan Italy I-20122 mbosis Ctr, I-20122 Milan, Italy Univ Hosp Skejby, Dept Clin Immunol, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, DK-8200 Aarhus N, Denmark Univ Hosp Skejby Aarhus Denmark N ombosis Ctr, DK-8200 Aarhus N, Denmark Univ Massachusetts, Mass Mem Healthcare, Worcester, MA 01605 USA Univ Massachusetts Worcester MA USA 01605 thcare, Worcester, MA 01605 USA Univ Med Ctr Utrecht, Van Creveldklin, NL-3508 GA Utrecht, Netherlands Univ Med Ctr Utrecht Utrecht Netherlands NL-3508 GA Utrecht, Netherlands Hop Edouard Herriot, F-69437 Lyon 03, France Hop Edouard Herriot Lyon France 03 uard Herriot, F-69437 Lyon 03, France Malmo Univ Hosp, Dept Coagulat Disorders, S-20502 Malmo, Sweden Malmo UnivHosp Malmo Sweden S-20502 at Disorders, S-20502 Malmo, Sweden St Jamess Hosp, Dublin 8, Ireland St Jamess Hosp Dublin Ireland 8St Jamess Hosp, Dublin 8, Ireland Indiana Univ, Med Ctr, Hemophilia Compren Ctr 17405, Indianapolis, IN 46260 USA Indiana Univ Indianapolis IN USA 46260 17405, Indianapolis, IN 46260 USA
Titolo Testata:
VOX SANGUINIS
fascicolo: 4, volume: 78, anno: 2000,
pagine: 256 - 261
SICI:
0042-9007(2000)78:4<256:TOTFHW>2.0.ZU;2-8
Fonte:
ISI
Lingua:
ENG
Soggetto:
RECOMBINANT FACTOR-VIIA; HEMOPHILIA-A PATIENTS; IMMUNE TOLERANCE; HIGH RESPONDER; INHIBITORS; INDUCTION;
Tipo documento:
Editorial Material
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
8
Recensione:
Indirizzi per estratti:
Indirizzo: Engelfriet, CP Serv Sanquin, Cent Lab Blood Transfus, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands Serv Sanquin Plesmanlaan 125 Amsterdam Netherlands NL-1066 CX
Citazione:
C.P. Engelfriet et al., "The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies", VOX SANGUIN, 78(4), 2000, pp. 256-261


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/09/20 alle ore 10:23:33